From a single case, investigators discover a web of HIV infection. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023. NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


From a single case, investigators discover a web of HIV infection. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5023.

AIDS Policy Law. 1995 Apr 21;10(7):1, 10-1. Unique Identifier : AIDSLINE AIDS/95700414


Abstract: A partner notification project was deemed successful when investigators at the Pennsylvania Department of Health were able to track down a network of 124 people after the initial index patient (a prison inmate) provided just four names. Investigators located the first four people, who all tested positive, and who identified other partners, who identified additional persons. Overall, forty-four people tested positive. Nearly all individuals had shared injection drugs or sex. Officials say the program was successful because of the precautions they took to ensure confidentiality and trust. Counseling was given to all people who were contacted; and all but three of the 121 people located agreed to HIV-antibody testing. The cooperation which the contacts gave health officials belies the popular belief that drug users or prisoners do not care about themselves or others. Health department staff took 2.5 to 10 hours to locate and interview each contact. The estimated cost was $13,969 or $583 for each case of newly discovered HIV infection.
Keywords: *Disease Notification Human HIV Antibodies/BLOOD HIV Infections/EPIDEMIOLOGY/*TRANSMISSION Pennsylvania/EPIDEMIOLOGY Prisoners Sexual Partners Substance Abuse, Intravenous NEWSLETTER ARTICLEKWDdiseasenotificationhumanhivantibodies/bloodhivinfections/epidemiology/KWDtransmissionpennsylvania/epidemiologyprisonerssexualpartnerssubstanceabuse,intravenousnewsletterarticle
951230
M95C3186

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .